Azathioprine
Treatment for Interstitial Lung Disease And Pulmonary Sarcoidosis
Typical Dosage: 1-2.5 mg/kg daily
Effectiveness
58%
Safety Score
30%
Clinical Trials
1
Participants
3K
Comparative Safety Scale(Higher is safer)
Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
30
DangerousModerateSafe
Treatment Details
Dosage Range
1-2.5 mg/kg daily
Time to Effect
3-6 months
Treatment Duration
1-2 years (or longer)
Evidence Quality
MODERATEConfidence Score
80%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$200
Monitoring:$750
Side Effect Mgmt:$300
Total Annual:$1,250
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
EXCELLENTQALYs Gained
Outcome-Based Costs
Cost per Responder
$2,083
Cost per Remission
$4,167
Azathioprine Outcomes
for Interstitial Lung Disease And Pulmonary Sarcoidosis
Efficacy Outcomes
Overall Effectiveness
+58%
Response Rate
+60%
Remission Rate
+30%
Common Side Effects
Nausea
+15%
Vomiting
+8%
Myelosuppression
+5%
Liver enzyme elevation
+8%
Increased infection risk
+10%
Sources:
Active Clinical Trials
No active trials currently recruiting for this treatment
No active trials found in ClinicalTrials.gov